Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
This statistic depicts the distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area. According to data, 31.9 percent of individuals participated to clinical studies carried out in the field of oncology and hematology, the therapeutic area with the largest percentage of patients. Moreover, neuroscientific studies held 22.6 percent of all participants, whereas the area of immunology and dermatology recorded 11.2 percent of patients.